Two Filipino scientists were chosen for Novartis mentorship in Basel, Switzerland.
Novartis Pharmaceuticals, in partnership with the Department of Science and Technology (DOST), through the Philippine Council for Health Research and Development (PCHRD), announced Dr. Leslie Michelle Dalmacio and Dr. Hiyas Junio of the University of the Philippines Manila and Diliman as the first Philippine delegates to the Novartis Next Generation Scientists last October 24, 2014.
The Novartis Next Generation Scientist Program aims to support talented post-graduate students from different countries through 3 month-long internships at the Novartis research facility in Basel, Switzerland. The Philippines is the first country in Asia to join in the initiative.
Dr. Nikolaos Tripodis, President and Managing Director of the Novartis Philippines, shared that the program is a testament to the commitment of company to afford their patients “good quality of life” through research.
Allocating as much as $9 billion a year, Novartis is one of the top funders of research and development in the world.
“Of course, to be able to use these billions of dollars, we need to have access to the best minds, not just within the company, but across the globe,” Dr. Tripodis said.
The two chosen delegates, bested the nominees from the top Philippine universities including UP Dilima, Manila, and Los Baños, University of Santo Tomas (UST), De La Salle University (DLSU) and Ateneo de Manila University (ADMU).
Dr. Tripodis explained that the internship program would be an excellent training ground for the two scientists to share and learn ideas from fellow scientist.
“Being a company that prides itself into attracting, retaining, and developing talent, we want to make sure that we provide the right platform to our associates to train and develop and, hopefully, one day, some of them can make their dreams come true,” he said.